Keyword
Menu
Home
About
Introducing Spineopedia
How We Score
Editors
Study Reviews
Resources
Spine Meetings
Calendar
Contact
Bone Therapeutics’ allogeneic cell therapy product, ALLOB, shows 90% fusion rate at 24 months in Phase IIa study in lumbar spinal fusion
Share
Posted:
October 14, 2020 at 4:19 pm / by
admin
/
comments (0)
tags:
Keyword
Recent Comments
Recent Comments